nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Altered state of consciousness—Vincristine—sarcoma	0.0391	0.0401	CcSEcCtD
Cyclizine—Apnoea—Etoposide—sarcoma	0.0172	0.0177	CcSEcCtD
Cyclizine—Urinary retention—Thiotepa—sarcoma	0.014	0.0144	CcSEcCtD
Cyclizine—Urinary retention—Vincristine—sarcoma	0.0124	0.0128	CcSEcCtD
Cyclizine—Blister—Epirubicin—sarcoma	0.0114	0.0117	CcSEcCtD
Cyclizine—Hepatobiliary disease—Thiotepa—sarcoma	0.0108	0.011	CcSEcCtD
Cyclizine—Agranulocytosis—Thiotepa—sarcoma	0.0106	0.0109	CcSEcCtD
Cyclizine—Agranulocytosis—Dactinomycin—sarcoma	0.0105	0.0108	CcSEcCtD
Cyclizine—Blister—Doxorubicin—sarcoma	0.0105	0.0108	CcSEcCtD
Cyclizine—Hepatitis—Dactinomycin—sarcoma	0.0101	0.0104	CcSEcCtD
Cyclizine—Connective tissue disorder—Thiotepa—sarcoma	0.01	0.0103	CcSEcCtD
Cyclizine—Drowsiness—Mitoxantrone—sarcoma	0.00983	0.0101	CcSEcCtD
Cyclizine—Eye disorder—Thiotepa—sarcoma	0.00955	0.0098	CcSEcCtD
Cyclizine—Jaundice cholestatic—Epirubicin—sarcoma	0.00932	0.00957	CcSEcCtD
Cyclizine—Agranulocytosis—Mitoxantrone—sarcoma	0.00917	0.00941	CcSEcCtD
Cyclizine—Chills—Thiotepa—sarcoma	0.00917	0.00941	CcSEcCtD
Cyclizine—Chills—Dactinomycin—sarcoma	0.0091	0.00934	CcSEcCtD
Cyclizine—Bronchospasm—Etoposide—sarcoma	0.00902	0.00926	CcSEcCtD
Cyclizine—Mental disorder—Thiotepa—sarcoma	0.00895	0.00919	CcSEcCtD
Cyclizine—Connective tissue disorder—Vincristine—sarcoma	0.0089	0.00914	CcSEcCtD
Cyclizine—Erythema—Thiotepa—sarcoma	0.00889	0.00913	CcSEcCtD
Cyclizine—Erythema—Dactinomycin—sarcoma	0.00883	0.00906	CcSEcCtD
Cyclizine—Hepatitis—Mitoxantrone—sarcoma	0.00882	0.00906	CcSEcCtD
Cyclizine—Tension—Thiotepa—sarcoma	0.00873	0.00896	CcSEcCtD
Cyclizine—Dyskinesia—Epirubicin—sarcoma	0.00871	0.00895	CcSEcCtD
Cyclizine—Nervousness—Thiotepa—sarcoma	0.00864	0.00887	CcSEcCtD
Cyclizine—Jaundice cholestatic—Doxorubicin—sarcoma	0.00862	0.00885	CcSEcCtD
Cyclizine—Vision blurred—Thiotepa—sarcoma	0.00838	0.0086	CcSEcCtD
Cyclizine—Agitation—Thiotepa—sarcoma	0.00817	0.00839	CcSEcCtD
Cyclizine—Injection site reaction—Epirubicin—sarcoma	0.00814	0.00836	CcSEcCtD
Cyclizine—Dyskinesia—Doxorubicin—sarcoma	0.00806	0.00828	CcSEcCtD
Cyclizine—Mental disorder—Vincristine—sarcoma	0.00794	0.00815	CcSEcCtD
Cyclizine—Chills—Mitoxantrone—sarcoma	0.00791	0.00813	CcSEcCtD
Cyclizine—Hepatobiliary disease—Etoposide—sarcoma	0.00773	0.00794	CcSEcCtD
Cyclizine—Convulsion—Thiotepa—sarcoma	0.0077	0.00791	CcSEcCtD
Cyclizine—Erythema—Mitoxantrone—sarcoma	0.00768	0.00788	CcSEcCtD
Cyclizine—Hypertension—Thiotepa—sarcoma	0.00768	0.00788	CcSEcCtD
Cyclizine—Agranulocytosis—Etoposide—sarcoma	0.00763	0.00783	CcSEcCtD
Cyclizine—Injection site reaction—Doxorubicin—sarcoma	0.00753	0.00773	CcSEcCtD
Cyclizine—Agitation—Vincristine—sarcoma	0.00725	0.00744	CcSEcCtD
Cyclizine—Vision blurred—Mitoxantrone—sarcoma	0.00724	0.00743	CcSEcCtD
Cyclizine—Nervous system disorder—Thiotepa—sarcoma	0.00712	0.00731	CcSEcCtD
Cyclizine—Tachycardia—Thiotepa—sarcoma	0.00708	0.00727	CcSEcCtD
Cyclizine—Skin disorder—Thiotepa—sarcoma	0.00705	0.00724	CcSEcCtD
Cyclizine—Thrombophlebitis—Epirubicin—sarcoma	0.00687	0.00705	CcSEcCtD
Cyclizine—Eye disorder—Etoposide—sarcoma	0.00686	0.00704	CcSEcCtD
Cyclizine—Convulsion—Vincristine—sarcoma	0.00683	0.00701	CcSEcCtD
Cyclizine—Hypertension—Vincristine—sarcoma	0.00681	0.00699	CcSEcCtD
Cyclizine—Hepatic function abnormal—Epirubicin—sarcoma	0.0068	0.00698	CcSEcCtD
Cyclizine—Convulsion—Mitoxantrone—sarcoma	0.00665	0.00683	CcSEcCtD
Cyclizine—Hypertension—Mitoxantrone—sarcoma	0.00663	0.00681	CcSEcCtD
Cyclizine—Chills—Etoposide—sarcoma	0.00658	0.00676	CcSEcCtD
Cyclizine—Paraesthesia—Thiotepa—sarcoma	0.00652	0.00669	CcSEcCtD
Cyclizine—Somnolence—Thiotepa—sarcoma	0.00645	0.00662	CcSEcCtD
Cyclizine—Anaphylactic shock—Vincristine—sarcoma	0.00644	0.00661	CcSEcCtD
Cyclizine—Thrombophlebitis—Doxorubicin—sarcoma	0.00635	0.00652	CcSEcCtD
Cyclizine—Nervous system disorder—Vincristine—sarcoma	0.00631	0.00648	CcSEcCtD
Cyclizine—Hepatic function abnormal—Doxorubicin—sarcoma	0.00629	0.00646	CcSEcCtD
Cyclizine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00627	0.00643	CcSEcCtD
Cyclizine—Dermatitis bullous—Epirubicin—sarcoma	0.00622	0.00639	CcSEcCtD
Cyclizine—Constipation—Thiotepa—sarcoma	0.00621	0.00637	CcSEcCtD
Cyclizine—Pain—Thiotepa—sarcoma	0.00621	0.00637	CcSEcCtD
Cyclizine—Pain—Dactinomycin—sarcoma	0.00616	0.00632	CcSEcCtD
Cyclizine—Muscle spasms—Etoposide—sarcoma	0.00614	0.0063	CcSEcCtD
Cyclizine—Tachycardia—Mitoxantrone—sarcoma	0.00612	0.00628	CcSEcCtD
Cyclizine—Skin disorder—Mitoxantrone—sarcoma	0.00609	0.00625	CcSEcCtD
Cyclizine—Hypotension—Vincristine—sarcoma	0.00601	0.00617	CcSEcCtD
Cyclizine—Hypotension—Mitoxantrone—sarcoma	0.00586	0.00601	CcSEcCtD
Cyclizine—Insomnia—Vincristine—sarcoma	0.00582	0.00598	CcSEcCtD
Cyclizine—Paraesthesia—Vincristine—sarcoma	0.00578	0.00593	CcSEcCtD
Cyclizine—Urticaria—Thiotepa—sarcoma	0.00577	0.00592	CcSEcCtD
Cyclizine—Dermatitis bullous—Doxorubicin—sarcoma	0.00576	0.00591	CcSEcCtD
Cyclizine—Paraesthesia—Mitoxantrone—sarcoma	0.00563	0.00578	CcSEcCtD
Cyclizine—Somnolence—Mitoxantrone—sarcoma	0.00557	0.00572	CcSEcCtD
Cyclizine—Convulsion—Etoposide—sarcoma	0.00553	0.00568	CcSEcCtD
Cyclizine—Hypertension—Etoposide—sarcoma	0.00551	0.00566	CcSEcCtD
Cyclizine—Pain—Vincristine—sarcoma	0.0055	0.00565	CcSEcCtD
Cyclizine—Constipation—Vincristine—sarcoma	0.0055	0.00565	CcSEcCtD
Cyclizine—SULT1E1—hematopoietic system—sarcoma	0.00546	0.211	CbGeAlD
Cyclizine—Constipation—Mitoxantrone—sarcoma	0.00536	0.0055	CcSEcCtD
Cyclizine—Pain—Mitoxantrone—sarcoma	0.00536	0.0055	CcSEcCtD
Cyclizine—Hypersensitivity—Thiotepa—sarcoma	0.00535	0.00549	CcSEcCtD
Cyclizine—Hypersensitivity—Dactinomycin—sarcoma	0.00531	0.00545	CcSEcCtD
Cyclizine—Anaphylactic shock—Etoposide—sarcoma	0.00521	0.00535	CcSEcCtD
Cyclizine—Asthenia—Thiotepa—sarcoma	0.00521	0.00535	CcSEcCtD
Cyclizine—Asthenia—Dactinomycin—sarcoma	0.00517	0.00531	CcSEcCtD
Cyclizine—Pruritus—Thiotepa—sarcoma	0.00513	0.00527	CcSEcCtD
Cyclizine—Tachycardia—Etoposide—sarcoma	0.00509	0.00522	CcSEcCtD
Cyclizine—Skin disorder—Etoposide—sarcoma	0.00506	0.0052	CcSEcCtD
Cyclizine—Urticaria—Mitoxantrone—sarcoma	0.00498	0.00511	CcSEcCtD
Cyclizine—Hypotension—Etoposide—sarcoma	0.00487	0.005	CcSEcCtD
Cyclizine—Dizziness—Thiotepa—sarcoma	0.0048	0.00493	CcSEcCtD
Cyclizine—Hypersensitivity—Vincristine—sarcoma	0.00474	0.00487	CcSEcCtD
Cyclizine—Paraesthesia—Etoposide—sarcoma	0.00468	0.00481	CcSEcCtD
Cyclizine—Somnolence—Etoposide—sarcoma	0.00463	0.00476	CcSEcCtD
Cyclizine—Hypersensitivity—Mitoxantrone—sarcoma	0.00462	0.00474	CcSEcCtD
Cyclizine—Asthenia—Vincristine—sarcoma	0.00462	0.00474	CcSEcCtD
Cyclizine—Drowsiness—Epirubicin—sarcoma	0.00458	0.0047	CcSEcCtD
Cyclizine—Headache—Thiotepa—sarcoma	0.00455	0.00467	CcSEcCtD
Cyclizine—Asthenia—Mitoxantrone—sarcoma	0.0045	0.00462	CcSEcCtD
Cyclizine—Pain—Etoposide—sarcoma	0.00446	0.00458	CcSEcCtD
Cyclizine—Constipation—Etoposide—sarcoma	0.00446	0.00458	CcSEcCtD
Cyclizine—Hepatobiliary disease—Epirubicin—sarcoma	0.00433	0.00445	CcSEcCtD
Cyclizine—Agranulocytosis—Epirubicin—sarcoma	0.00428	0.00439	CcSEcCtD
Cyclizine—Dizziness—Vincristine—sarcoma	0.00426	0.00437	CcSEcCtD
Cyclizine—Drowsiness—Doxorubicin—sarcoma	0.00424	0.00435	CcSEcCtD
Cyclizine—Urticaria—Etoposide—sarcoma	0.00414	0.00425	CcSEcCtD
Cyclizine—Hepatitis—Epirubicin—sarcoma	0.00411	0.00422	CcSEcCtD
Cyclizine—Connective tissue disorder—Epirubicin—sarcoma	0.00404	0.00415	CcSEcCtD
Cyclizine—Headache—Vincristine—sarcoma	0.00403	0.00414	CcSEcCtD
Cyclizine—Hepatobiliary disease—Doxorubicin—sarcoma	0.00401	0.00412	CcSEcCtD
Cyclizine—Agranulocytosis—Doxorubicin—sarcoma	0.00396	0.00406	CcSEcCtD
Cyclizine—Headache—Mitoxantrone—sarcoma	0.00393	0.00403	CcSEcCtD
Cyclizine—SULT1E1—lymphoid tissue—sarcoma	0.00385	0.148	CbGeAlD
Cyclizine—Eye disorder—Epirubicin—sarcoma	0.00384	0.00395	CcSEcCtD
Cyclizine—Hypersensitivity—Etoposide—sarcoma	0.00384	0.00394	CcSEcCtD
Cyclizine—Hepatitis—Doxorubicin—sarcoma	0.00381	0.00391	CcSEcCtD
Cyclizine—Asthenia—Etoposide—sarcoma	0.00374	0.00384	CcSEcCtD
Cyclizine—Connective tissue disorder—Doxorubicin—sarcoma	0.00374	0.00384	CcSEcCtD
Cyclizine—Chills—Epirubicin—sarcoma	0.00369	0.00379	CcSEcCtD
Cyclizine—Pruritus—Etoposide—sarcoma	0.00369	0.00379	CcSEcCtD
Cyclizine—Mental disorder—Epirubicin—sarcoma	0.0036	0.0037	CcSEcCtD
Cyclizine—Erythema—Epirubicin—sarcoma	0.00358	0.00368	CcSEcCtD
Cyclizine—Eye disorder—Doxorubicin—sarcoma	0.00356	0.00365	CcSEcCtD
Cyclizine—Tension—Epirubicin—sarcoma	0.00351	0.00361	CcSEcCtD
Cyclizine—Nervousness—Epirubicin—sarcoma	0.00348	0.00357	CcSEcCtD
Cyclizine—Dizziness—Etoposide—sarcoma	0.00345	0.00354	CcSEcCtD
Cyclizine—Muscle spasms—Epirubicin—sarcoma	0.00344	0.00353	CcSEcCtD
Cyclizine—Chills—Doxorubicin—sarcoma	0.00341	0.00351	CcSEcCtD
Cyclizine—Vision blurred—Epirubicin—sarcoma	0.00337	0.00346	CcSEcCtD
Cyclizine—Mental disorder—Doxorubicin—sarcoma	0.00333	0.00342	CcSEcCtD
Cyclizine—Erythema—Doxorubicin—sarcoma	0.00331	0.0034	CcSEcCtD
Cyclizine—Agitation—Epirubicin—sarcoma	0.00329	0.00338	CcSEcCtD
Cyclizine—Headache—Etoposide—sarcoma	0.00327	0.00335	CcSEcCtD
Cyclizine—Tension—Doxorubicin—sarcoma	0.00325	0.00334	CcSEcCtD
Cyclizine—Nervousness—Doxorubicin—sarcoma	0.00322	0.0033	CcSEcCtD
Cyclizine—Muscle spasms—Doxorubicin—sarcoma	0.00319	0.00327	CcSEcCtD
Cyclizine—Vision blurred—Doxorubicin—sarcoma	0.00312	0.00321	CcSEcCtD
Cyclizine—Convulsion—Epirubicin—sarcoma	0.0031	0.00318	CcSEcCtD
Cyclizine—Hypertension—Epirubicin—sarcoma	0.00309	0.00317	CcSEcCtD
Cyclizine—Agitation—Doxorubicin—sarcoma	0.00304	0.00313	CcSEcCtD
Cyclizine—SULT1E1—testis—sarcoma	0.00299	0.116	CbGeAlD
Cyclizine—Anaphylactic shock—Epirubicin—sarcoma	0.00292	0.003	CcSEcCtD
Cyclizine—Convulsion—Doxorubicin—sarcoma	0.00287	0.00295	CcSEcCtD
Cyclizine—Nervous system disorder—Epirubicin—sarcoma	0.00287	0.00294	CcSEcCtD
Cyclizine—Hypertension—Doxorubicin—sarcoma	0.00286	0.00294	CcSEcCtD
Cyclizine—Tachycardia—Epirubicin—sarcoma	0.00285	0.00293	CcSEcCtD
Cyclizine—Skin disorder—Epirubicin—sarcoma	0.00284	0.00291	CcSEcCtD
Cyclizine—SULT1E1—liver—sarcoma	0.00283	0.109	CbGeAlD
Cyclizine—Hypotension—Epirubicin—sarcoma	0.00273	0.0028	CcSEcCtD
Cyclizine—Anaphylactic shock—Doxorubicin—sarcoma	0.0027	0.00278	CcSEcCtD
Cyclizine—Nervous system disorder—Doxorubicin—sarcoma	0.00265	0.00272	CcSEcCtD
Cyclizine—Insomnia—Epirubicin—sarcoma	0.00264	0.00271	CcSEcCtD
Cyclizine—Tachycardia—Doxorubicin—sarcoma	0.00264	0.00271	CcSEcCtD
Cyclizine—Skin disorder—Doxorubicin—sarcoma	0.00263	0.0027	CcSEcCtD
Cyclizine—Paraesthesia—Epirubicin—sarcoma	0.00262	0.00269	CcSEcCtD
Cyclizine—Somnolence—Epirubicin—sarcoma	0.0026	0.00267	CcSEcCtD
Cyclizine—Hypotension—Doxorubicin—sarcoma	0.00253	0.00259	CcSEcCtD
Cyclizine—Constipation—Epirubicin—sarcoma	0.0025	0.00257	CcSEcCtD
Cyclizine—Pain—Epirubicin—sarcoma	0.0025	0.00257	CcSEcCtD
Cyclizine—Insomnia—Doxorubicin—sarcoma	0.00245	0.00251	CcSEcCtD
Cyclizine—Paraesthesia—Doxorubicin—sarcoma	0.00243	0.00249	CcSEcCtD
Cyclizine—Somnolence—Doxorubicin—sarcoma	0.0024	0.00247	CcSEcCtD
Cyclizine—Urticaria—Epirubicin—sarcoma	0.00232	0.00238	CcSEcCtD
Cyclizine—Constipation—Doxorubicin—sarcoma	0.00231	0.00237	CcSEcCtD
Cyclizine—Pain—Doxorubicin—sarcoma	0.00231	0.00237	CcSEcCtD
Cyclizine—SULT1E1—lymph node—sarcoma	0.00217	0.0838	CbGeAlD
Cyclizine—Hypersensitivity—Epirubicin—sarcoma	0.00215	0.00221	CcSEcCtD
Cyclizine—Urticaria—Doxorubicin—sarcoma	0.00215	0.00221	CcSEcCtD
Cyclizine—Asthenia—Epirubicin—sarcoma	0.0021	0.00215	CcSEcCtD
Cyclizine—Pruritus—Epirubicin—sarcoma	0.00207	0.00212	CcSEcCtD
Cyclizine—Hypersensitivity—Doxorubicin—sarcoma	0.00199	0.00204	CcSEcCtD
Cyclizine—Asthenia—Doxorubicin—sarcoma	0.00194	0.00199	CcSEcCtD
Cyclizine—Dizziness—Epirubicin—sarcoma	0.00193	0.00198	CcSEcCtD
Cyclizine—Pruritus—Doxorubicin—sarcoma	0.00191	0.00196	CcSEcCtD
Cyclizine—Headache—Epirubicin—sarcoma	0.00183	0.00188	CcSEcCtD
Cyclizine—Dizziness—Doxorubicin—sarcoma	0.00179	0.00184	CcSEcCtD
Cyclizine—Headache—Doxorubicin—sarcoma	0.00169	0.00174	CcSEcCtD
Cyclizine—CYP2C9—mammary gland—sarcoma	0.00163	0.0627	CbGeAlD
Cyclizine—HRH1—myometrium—sarcoma	0.00114	0.0439	CbGeAlD
Cyclizine—CYP2C9—hematopoietic system—sarcoma	0.000991	0.0382	CbGeAlD
Cyclizine—HRH1—hematopoietic system—sarcoma	0.000977	0.0377	CbGeAlD
Cyclizine—HRH1—connective tissue—sarcoma	0.000941	0.0363	CbGeAlD
Cyclizine—HRH1—smooth muscle tissue—sarcoma	0.000861	0.0332	CbGeAlD
Cyclizine—HRH1—tendon—sarcoma	0.000647	0.0249	CbGeAlD
Cyclizine—HRH1—testis—sarcoma	0.000535	0.0207	CbGeAlD
Cyclizine—CYP2C9—liver—sarcoma	0.000513	0.0198	CbGeAlD
Cyclizine—HRH1—lymph node—sarcoma	0.000388	0.015	CbGeAlD
